U.S. FDA OKs New Drug for Diabetes

A new type of diabetes drug that helps the body control blood sugar won U.S.
Food and Drug Administration approval, the agency said on Tuesday. Merck &
Co. Inc.'s oral diabetes drug Januvia, generically known as sitagliptin, is
the first in a new class of drugs that aims to treat the disease with fewer
side effects. The FDA approved the once-a-day drug to treat type 2 diabetes,
which affects the majority of the nearly 21 million Americans with the
disease.

Learn more>>

U.S. FDA OKs New Merck Drug for Diabetes